Charles River Laboratories CRL Common stock, shares authorized (in shares)
Common stock, shares authorized (in shares) at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's common stock, shares authorized (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's common stock, shares authorized (in shares)?
- Charles River Laboratories (CRL) reported common stock, shares authorized (in shares) of $120M in Q1 2026.
- How has Charles River Laboratories's common stock, shares authorized (in shares) changed year-over-year?
- Charles River Laboratories's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $120M to $120M.
- What is the long-term trend for Charles River Laboratories's common stock, shares authorized (in shares)?
- Over 5 years (2020 to 2025), Charles River Laboratories's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $120M to $120M.